This announcement is a separate document:
海通证券股份有限公司关于迈威（上海）生物科技股份有限公司2023年度持续督导现场检查报告
Haitong Securities Co., Ltd. report on the 2023 continuous supervision site inspection report of Maiwei (Shanghai) Biotechnology Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.